Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Theophylline in Early-Stage CLL
NCT00003808Phase 2Completed
- Sponsor
- Eastern Cooperative Oncology Group
- Start
- Aug 1999
- Primary completion
- Sep 2002
- Modality
- Small Molecules
- Countries
- 3
01
Overview
Phase 2, open-label, single-arm trial of theophylline in chronic lymphocytic leukemia (CLL), sponsored by Eastern Cooperative Oncology Group. Primary endpoint: Response Rate at 6 months. Started Aug 1999; status: completed.
02
Drugs
theophylline
03
Conditions
chronic lymphocytic leukemia (CLL)
Beyond the preview
Go deeper on NCT00003808.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00003808.